Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inverness is buying HemoSense for $171.6mm in stock

Executive Summary

Inverness Medical Innovations will acquire point-of-care testing company HemoSense for $171.6mm in stock or 10.5 times HemoSense's 2006 revenues.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Hematology, Coagulation
    • Therapeutic Drug Monitoring
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register